World Lymphoma Drugs Market to Grow at 8.02% CAGR by 2021 Driven by Increase in Industry-Academia Collaborations

PUNE, India, June 12, 2017 /PRNewswire-iReach/ -- The latest trend gaining momentum in the lymphoma drugs market is increasing consolidation in the cancer treatment market. Past several years have witnessed significant consolidation in the cancer treatment industry. There can be seen a trend of movement of cancer treatment from clinics to hospitals. Studies have shown that there is a rise in a number of oncology clinics that got acquired by hospitals.

Complete report on lymphoma drugs market spread across 86 pages, analyzing 4 major companies and providing 53 data exhibits is now available at http://www.reportsnreports.com/reports/1041372-global-lymphoma-drugs-market-2017-2021.html .

According to the lymphoma drugs market report, one of the major drivers for this market is increase in industry-academia collaborations. The key players in the market are increasingly extending their support to academic institutions to support the R&D of innovative drugs. Such collaborations enable the amalgamation of research expertise of academic institutions with the marketing intelligence of pharmaceutical companies, besides providing funds to conduct trial studies. For instance, Merck's cancer segment collaborated with academic institutions such as BioMed X to support R&D activities in the development of monoclonal antibodies (mAbs) for cancer segment.

The following companies as the key players in the global lymphoma drugs market: Celgene, F. Hoffmann-La Roche, Johnson & Johnson, and Seattle Genetics.  Other prominent vendors in the market are: Amgen, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Novartis, Pfizer, Takeda Pharmaceuticals, and Teva Pharmaceutical Industries. Order a copy of Global Lymphoma Drugs Market 2017-2021 report @http://www.reportsnreports.com/purchase.aspx?name=1041372 .

Global Lymphoma Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. The report covers the present scenario and the growth prospects of the global lymphoma drugs market for 2017-2021. To calculate the market size, the report considers the sales from branded, generic, and off-label drugs.

Further, the report states that one of the major factors hindering the growth of this market is high cost of lymphoma treatment. The high cost of treatment is a major problem for the lymphoma patients across the globe. Many of the treatment options available for the individuals are out of their budget and ultimately force the individual or the payer to skip the treatment. Virtual monopoly among the drug manufacturers and the high cost of R&D are some of the major factors for the high cost of lymphoma treatment. A large proportion of population either skips the treatment or leaves it in the middle. Despite availing the costly treatment, reoccurrence of the disease quadruples the issues and negatively affects the patient adherence.

The lymphoma drugs market study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
 

Media Contact:Ritesh Tiwari, ReportsnReports, + 1 888 391 5441, sales@reportsandreports.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE ReportsnReports